Jaguar Health received formal notice from The Nasdaq Stock Market that Jaguar has regained compliance with Nasdaq’s minimum bid price requirement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAGX:
- Jaguar Health Stockholders Approve Key Proposals at 2024 Meeting
- Jaguar Health to report Phase 3 OnTarget trial results on or before July 23
- Jaguar Health executes out-license dal with JV Magdalena Biosciences
- Jaguar Health anounces results of investigator-initiated trial of crofelemer
- Jaguar Animal Health trading halted, news pending